Randa Zeitouni, PhD, is an executive leader with a career that spans 27 years in both aca-demic and pharmaceutical industry including 23 years experience in Clinical Research, ini-tially in a clinical capacity, then with the last 19 years in Project Management roles. Randa worked for small, midsize and large CROs managing and providing oversight to cross-functional teams executing full service large-scale projects and programs. She has suc-cessfully planned, directed and delivered a number of high profile and very well known global clinical trials that resulted in innovative breakthrough therapies and changed the standard of care. She also worked as a consultant to Pharma and Biotech companies providing CRO management and oversight. A pharmacy graduate she holds a MSc in Clinical Biochemistry from the University of Newcastle upon Tyne, UK, an AES in Haematology and a PhD in Pharmaceutical Sciences from the University of Lyon I, France. Randa is a Project Management Professional, a Chartered Scientist and Fellow at the Institute of Biomedical Science.
Elizabeth Garofalo, MD Expert CNS Consultant
Elizabeth Garofalo, MD, has 25 years of drug development experience in clinical development and regulatory affairs. Dr. Garofalo has worked extensively in CNS drug development including in the pediatric population. Prior to joining Nuvelution she was SVP, Global Head of Clinical Development, Novartis. Dr. Garofalo joined Novartis in 2011 as SVP, Neuroscience Development Franchise Head. Prior to Novartis she was Vice President, CNS Therapy Area, Astellas and Executive Director Regulatory Affairs, Pfizer Research and Development. She has been instrumental in the development and/or approval of several CNS blockbuster products including Neurontin®, Lyrica® and Gilenya®. Dr. Garofalo received her medical degree from Indiana University where she completed a Pediatrics residency. She completed her Pediatric Neurology and Epilepsy Fellowships at the University of Michigan where she became an academic Pediatric Neurologist. She is board certified in Pediatrics, in Neurology with Special Competence in Child Neurology. She was an Adjunct Associate Professor of Pediatrics at the University of Michigan until 2011.